Search clinical trials for: Enzalutamide and Dutasteride or finasteride
Total 4332 results
-
University of RochesterCompletedProstate CancerUnited States
-
GlaxoSmithKlineCompletedAndrogenetic AlopeciaJapan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
-
GlaxoSmithKlineCompleted
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
GlaxoSmithKlineCompleted
-
Turku University HospitalRecruitingProstatic Hyperplasia | Prostate CancerFinland
-
University of SydneyCanadian Cancer Trials Group; Australian and New Zealand Urogenital and Prostate... and other collaboratorsActive, not recruitingProstatic NeoplasmsNew Zealand, Canada, United States, Australia, United Kingdom, Ireland
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
University of BirminghamUnknown
-
Polichem S.A.CompletedAlopecia, AndrogeneticBelgium, Germany, Hungary, Russian Federation, Spain
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Terminated
-
Kasiak Research Pvt. Ltd.Unknown
-
GlaxoSmithKlineCompletedProstatic HyperplasiaAustralia
-
Case Comprehensive Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
Elorac, Inc.Completed
-
Bio-innova Co., LtdNot yet recruiting
-
GlaxoSmithKlineCompletedProstatic Hyperplasia | Benign Prostatic HyperplasiaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
Spanish Oncology Genito-Urinary GroupAstellas Pharma Inc; Apices Soluciones S.L.CompletedHormone-refractory Prostate CancerSpain
-
Memorial Sloan Kettering Cancer CenterMedivation, Inc.CompletedPrimary Peritoneal Carcinoma | Fallopian Tube | Advanced Epithelial Ovarian | Recurrent Epithelial OvarianUnited States
-
University of SydneyNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingProstatic NeoplasmsUnited States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
-
EMSRecruitingAndrogenetic AlopeciaBrazil
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
Hospices Civils de LyonUnknown
-
University of ChicagoActive, not recruitingProstate CancerUnited States
-
Iran University of Medical SciencesFiruzgar hospital affiliated to Iran University of Medical SciencesCompletedIdiopathic Hirsutism
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
SOLTI Breast Cancer Research GroupTerminated
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
University of RochesterAstellas Pharma IncTerminated
-
The Netherlands Cancer InstituteAstellas Pharma IncCompletedProstate Cancer | Androgen Receptor Abnormal | DNA
-
GlaxoSmithKlineCompletedProstatic HyperplasiaUnited States
-
Seoul National University HospitalGlaxoSmithKline; The Korean Urological AssociationCompletedBenign Prostatic Hyperplasia
-
CancerCare ManitobaTerminatedNon-small Cell Lung CancerCanada
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruiting
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Astellas Pharma IncMedivation, Inc.CompletedProstate CancerBelgium, Czechia, Denmark, Germany
-
Polichem S.A.Completed
-
National Cancer Institute (NCI)RecruitingRecurrent Prostate Cancer | Prostate Cancer | PET PositiveUnited States
-
Chinese University of Hong KongJanssen, LPTerminated
-
GlaxoSmithKlineCompletedProstatic HyperplasiaJapan
-
Northwestern UniversityGlaxoSmithKlineTerminatedBenign Prostatic Hyperplasia
-
University of Michigan Rogel Cancer CenterCompletedProstate CancerUnited States
-
Samsung Medical CenterNot yet recruiting
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy